Navigation Links
UT Southwestern Responds to VA Announcement
Date:8/26/2009

DALLAS, Aug. 26 /PRNewswire-USNewswire/ -- UT Southwestern has issued the following statement in regard to today's news release by the Veterans Administration:

We regret the VA's unilateral decision to not renew the contract supporting vital research focused on veterans suffering from Gulf War syndrome being carried out by UT Southwestern investigators and their collaborators elsewhere.

We strongly disagree with the VA's characterization of the facts related to our Gulf War research contract. We were surprised to learn of their action, especially since we have been working diligently and in good faith with the VA to resolve all areas of disagreement.

We remain committed to performing research that improves the condition of those who have served our country.

This news release is available on our World Wide Web home page at www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via e-mail, subscribe at www.utsouthwestern.edu/receivenews


'/>"/>
SOURCE UT Southwestern Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. UT Southwestern physicians bust myths about insulin
2. UT Southwestern researchers launch study into search-and-destroy antigen for deadly skin cancer
3. Dysport proves safe, effective anti-wrinkle treatment, UT Southwestern plastic surgeons find
4. Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report
5. UT Southwestern, UT Arlington to develop magnetic surgery tools
6. UT Southwestern researcher named HHMI Early Career Physician-Scientist
7. Former Gov. Bill Clements Makes Historic Gift to UT Southwestern With $100 Million Transformative Contribution
8. UT Southwesterns Olson wins prestigious French award for heart research
9. Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report
10. UT Southwestern University Hospital earns outstanding achievement award for cancer care
11. UT Southwestern researchers reveal how the brain processes important information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... , ... Goodcents Deli Fresh Subs today announced the opening of a new ... St. Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by ... locations in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and ... has selected 21 leaders from government, business and civil society in 11 countries across ... U.S. this fall, engaging in a transformative exchange of knowledge and ideas with the ...
(Date:6/23/2017)... ... , ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an ... 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for ... Denmark in 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in ...
(Date:6/23/2017)... TX (PRWEB) , ... June 23, 2017 , ... All-Star ... to residential and business clients throughout eastern Texas, is announcing the launch of a ... , Recent breast cancer statistics in the United States reveal that an estimated 252, ...
(Date:6/22/2017)... ... 22, 2017 , ... Plastic Surgery Associates is proud to report that founding ... year, research and information firm, Castle Connolly, releases their list of the most notable ... the 3rd time that Dr. Canales has been recognized by Castle Connolly. ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ... that they will host a live, complimentary webinar titled, ... the benchtop to the real world" on Wednesday June ... This webinar will feature interviews with ... look into the manipulation techniques abusers use to prepare ...
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: